These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29030533)

  • 1. Progress towards TB reduction targets is faltering, report finds.
    Cousins S
    BMJ; 2017 Oct; 359():j4758. PubMed ID: 29030533
    [No Abstract]   [Full Text] [Related]  

  • 2. Issues facing TB control (7). Multiple drug-resistant tuberculosis.
    Raviglione MC
    Scott Med J; 2000 Oct; 45(5 Suppl):52-5; discussion 56. PubMed ID: 11130318
    [No Abstract]   [Full Text] [Related]  

  • 3. The need for global action against multidrug-resistant tuberculosis.
    Heymann SJ; Brewer TF; Wilson ME; Fineberg HV
    JAMA; 1999 Jun; 281(22):2138-40. PubMed ID: 10367825
    [No Abstract]   [Full Text] [Related]  

  • 4. Ending tuberculosis by 2030: can we do it?
    Suthar AB; Zachariah R; Harries AD
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1148-54. PubMed ID: 27510238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis control goals unlikely to be met by 2005.
    Sharma DC
    Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013
    [No Abstract]   [Full Text] [Related]  

  • 6. [Multidrug resistance tuberculosis - current problems].
    Kruczak K; Nizankowska-Mogilnicka E
    Pneumonol Alergol Pol; 2009; 77(3):276-83. PubMed ID: 19591099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Picking up the pace--scale-up of MDR tuberculosis treatment programs.
    Keshavjee S; Farmer PE
    N Engl J Med; 2010 Nov; 363(19):1781-4. PubMed ID: 21047219
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress towards achieving global tuberculosis control: so near, yet so far.
    Zumla A; Davies PD
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):285-6. PubMed ID: 27046703
    [No Abstract]   [Full Text] [Related]  

  • 9. Towards tuberculosis elimination: an action framework for low-incidence countries.
    Lönnroth K; Migliori GB; Abubakar I; D'Ambrosio L; de Vries G; Diel R; Douglas P; Falzon D; Gaudreau MA; Goletti D; González Ochoa ER; LoBue P; Matteelli A; Njoo H; Solovic I; Story A; Tayeb T; van der Werf MJ; Weil D; Zellweger JP; Abdel Aziz M; Al Lawati MR; Aliberti S; Arrazola de Oñate W; Barreira D; Bhatia V; Blasi F; Bloom A; Bruchfeld J; Castelli F; Centis R; Chemtob D; Cirillo DM; Colorado A; Dadu A; Dahle UR; De Paoli L; Dias HM; Duarte R; Fattorini L; Gaga M; Getahun H; Glaziou P; Goguadze L; Del Granado M; Haas W; Järvinen A; Kwon GY; Mosca D; Nahid P; Nishikiori N; Noguer I; O'Donnell J; Pace-Asciak A; Pompa MG; Popescu GG; Robalo Cordeiro C; Rønning K; Ruhwald M; Sculier JP; Simunović A; Smith-Palmer A; Sotgiu G; Sulis G; Torres-Duque CA; Umeki K; Uplekar M; van Weezenbeek C; Vasankari T; Vitillo RJ; Voniatis C; Wanlin M; Raviglione MC
    Eur Respir J; 2015 Apr; 45(4):928-52. PubMed ID: 25792630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estonia races to halt multidrug-resistant TB before HIV takes hold.
    Lindsay M
    Bull World Health Organ; 2002; 80(6):519. PubMed ID: 12132016
    [No Abstract]   [Full Text] [Related]  

  • 11. 'Universal' access for MDR-TB limited without the involvement of the private sector.
    Pinto L; Udwadia Z
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):851; author reply 851-2. PubMed ID: 21575312
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational 'DOTS plus' for the control of MDR-TB.
    Espinal MA; Dye C; Raviglione M; Kochi A
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):561-3. PubMed ID: 10423218
    [No Abstract]   [Full Text] [Related]  

  • 14. An epidemiological study of multi drug resistant tuberculosis cases registered under Revised National Tuberculosis Control Programme of Ahmedabad City.
    Bhatt G; Vyas S; Trivedil K
    Indian J Tuberc; 2012 Jan; 59(1):18-27. PubMed ID: 22670507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistant tuberculosis: what is to be done?
    Schluger NW
    Chest; 2009 Aug; 136(2):333-335. PubMed ID: 19666753
    [No Abstract]   [Full Text] [Related]  

  • 16. Infection Prevention And Control In TB Programs.
    Trusov A; Ismoilova J; Tonkel T; Aleksandrin A
    Health Aff (Millwood); 2016 Mar; 35(3):556. PubMed ID: 26953318
    [No Abstract]   [Full Text] [Related]  

  • 17. Stop TB Partnership has provided treatments for 10 million people in 6 years.
    Wkly Epidemiol Rec; 2007 Jun; 82(22/23):206-7. PubMed ID: 17542093
    [No Abstract]   [Full Text] [Related]  

  • 18. Scaling up interventions to achieve global tuberculosis control: progress and new developments.
    Raviglione M; Marais B; Floyd K; Lönnroth K; Getahun H; Migliori GB; Harries AD; Nunn P; Lienhardt C; Graham S; Chakaya J; Weyer K; Cole S; Kaufmann SH; Zumla A
    Lancet; 2012 May; 379(9829):1902-13. PubMed ID: 22608339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fight against tuberculosis in the world].
    El Kamel A; Joobeur S; Skhiri N; Cheikh Mhamed S; Mribah H; Rouatbi N
    Rev Pneumol Clin; 2015; 71(2-3):181-7. PubMed ID: 24878188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New tuberculosis tools are here: can we deliver them for maximal impact?
    Pai M; Memish ZA
    J Epidemiol Glob Health; 2013 Mar; 3(1):1-2. PubMed ID: 23856532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.